Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Triangle (HCTI) Long-Term Deferred Tax (2021 - 2025)

Historic Long-Term Deferred Tax for Healthcare Triangle (HCTI) over the last 5 years, with Q2 2025 value amounting to $887000.0.

  • Healthcare Triangle's Long-Term Deferred Tax changed N/A to $887000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $887000.0, marking a year-over-year change of. This contributed to the annual value of $1.3 million for FY2024, which is 773.44% down from last year.
  • Healthcare Triangle's Long-Term Deferred Tax amounted to $887000.0 in Q2 2025.
  • Healthcare Triangle's 5-year Long-Term Deferred Tax high stood at $2.4 million for Q4 2022, and its period low was $500000.0 during Q1 2025.
  • Moreover, its 5-year median value for Long-Term Deferred Tax was $1.4 million (2021), whereas its average is $1.3 million.
  • Per our database at Business Quant, Healthcare Triangle's Long-Term Deferred Tax soared by 7337.11% in 2022 and then tumbled by 4031.86% in 2023.
  • Over the past 5 years, Healthcare Triangle's Long-Term Deferred Tax (Quarter) stood at $1.4 million in 2021, then surged by 73.37% to $2.4 million in 2022, then crashed by 40.32% to $1.5 million in 2023, then decreased by 7.73% to $1.3 million in 2024, then crashed by 34.2% to $887000.0 in 2025.
  • Its last three reported values are $887000.0 in Q2 2025, $500000.0 for Q1 2025, and $1.3 million during Q4 2024.